P1.12-05 Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)

Detalles Bibliográficos
Autores principales: Zhang, Y.Z., Nicholson, A.G., Ly, F., Rice, A., Robertus, J.L., Lim, E., Begum, S., Buderi, S., Anikin, V., Finch, J., Asadi, N., Popat, S., McDonald, F., De Sousa, P., Molyneaux, P.L., Moffatt, M.F., Cookson, W.O., Kemp, S., Shah, P.L., Ridge, C.A., Desai, S., Padley, S., Devaraj, A., Jordan, S., Beddow, E., Brambilla, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
P1.12 Management of Lung Cancer in the Era of Covid-19, Sunday, August 7, 2022 - 17:00 - 19:00
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452039/
http://dx.doi.org/10.1016/j.jtho.2022.07.189
Descripción
Sumario:

Ejemplares similares